FDA Turns Attention To Generic Concerta...

November 14, 2014 4:59 AM

3 0

FDA Turns Attention To Generic Concerta...

The FDA has expressed concern that generic versions of attention deficit hyperactive disorder drug Concerta, manufactured by Mallinckrodt plc (MNK: Quote) and Kudco Ireland Ltd., may not produce the same therapeutic benefits for some patients as the brand-name drug.

The branded drug, Concerta, for the treatment of attention deficit hyperactive disorder in children, adolescents, and adults, was first approved by FDA in August 2000, and is manufactured by Janssen Pharmaceuticals Inc., a unit of Johnson & Johnson (JNJ: Quote).

Read more

To category page

Loading...